Evidence map›Paper›PMID 40663792›Full record

Observational studyJMIR human factors2025

Evaluating the Usability of an HIV Prevention Artificial Intelligence Chatbot in Malaysia: National Observational Study.

Zhao Ni, Sunyoung Oh, Rumana Saifi, Iskandar Azwa, Frederick L Altice

Abstract readObservational Study
In one paragraph

Observational study in JMIR human factors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhao NiSchool of Nursing, Yale University, 400 West Campus Drive, Orange, CT, 06477-3646, United States, 1 2037373039.ORCID 0000-0002-9185-9894
Sunyoung OhSchool of Nursing, Yale University, 400 West Campus Drive, Orange, CT, 06477-3646, United States, 1 2037373039.ORCID 0000-0002-7323-6175
Rumana SaifiCentre of Excellence for Research in Infectious Diseases & AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0001-9114-4728
Iskandar AzwaCentre of Excellence for Research in Infectious Diseases & AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0003-1977-6709
Frederick L AlticeCenter for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, CT, United States.ORCID 0000-0002-7860-693X

Funding

Developing an artificial intelligence-based mHealth intervention to increase HIV testing in MalaysiaR33TW011663 · FIC · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS, NI, ZHAO · 2022 to 2024
$936k
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in MalaysiaR21TW011663 · FIC · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS, NI, ZHAO · 2020 to 2021
$387k
FIC NIH HHS R21 TW011663FIC NIH HHS R33 TW011663
6 · The paper itself

Abstract

Background: Malaysia, an upper middle-income country in the Asia-Pacific region, has an HIV epidemic that has transitioned from needle sharing to sexual transmission, mainly in men who have sex with men (MSM). MSM are the most vulnerable population for HIV in Malaysia. In 2022, our team developed a web-based artificial intelligence (AI) chatbot and tested its feasibility and acceptability among MSM in Malaysia to promote HIV testing. To enhance the usability of the AI chatbot, we made it accessible to the public through the website called MYHIV365 and tested it in an observational study. Objective: This study aimed to test the usability of an AI chatbot in promoting HIV testing among MSM living in Malaysia. Methods: This observational study was conducted from August 2023 to March 2024 among 334 MSM. Participants were recruited through community outreach and social-networking apps using flyers. The interactions between participants and the AI chatbot were documented and retrieved from the chatbot developer's platform. Data were analyzed following a predefined metrics using R software (Posit Software, PBC). Results: The AI chatbot interacted with 334 participants, assisting them in receiving free HIV self-testing kits, offering information on HIV, pre-exposure prophylaxis (PrEP), and mental health, and providing details of 220 MSM-friendly clinics, including their addresses, phone numbers, and operating hours. After the study, 393 human-chatbot interactions were documented on the chatbot developer's platform. Most participants (304/334, 91.0%) interacted with the AI chatbot once, 30 (9.0%) engaged 2 or more times at different intervals. Participants' interaction time with the chatbot varied, ranging from 1 to 31 minutes. The AI chatbot properly addressed most participants' questions (362/393, 92.1%) about HIV and PrEP. However, in 31 interactions, participants posed additional questions to the chatbot that were not programmed into the chatbot algorithms, resulting in unanswered interactions. Conclusions: The web-based AI chatbot demonstrated high usability in delivering HIV self-testing kits and providing clinical information on HIV testing, PrEP, and mental health services. To enhance its usability in community and clinical settings, the chatbot must offer personalized health information and precise interaction, powered by sophisticated machine learning algorithms. In addition, establishing an effective connection between the AI chatbot and health care systems to eliminate stigma and discrimination toward MSM is crucial for the future implementation of AI chatbots.

Indexed as

Generative Artificial IntelligenceHIV InfectionsHIV TestingHomosexuality, MaleAdultHumansMalaysiaMaleMiddle Agedartificial intelligencechatbotfeasibilityHIV preventionHIV testingmen who have sex with menmHealthmobile healthMSMpre-exposure prophylaxisPrEPusability

Identifiers

PMID40663792
PMCPMC12283058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.